跳至主要内容
临床试验/NCT01113658
NCT01113658撤回不适用

Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System

3M4 个研究点 分布在 1 个国家开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
3M
试验地点
4
主要终点
Frequency of complaints about device use and operation

研究概览

简要总结

The purpose of this study is to assess the efficacy of design improvements of the Spiracur SNaP Wound Care System. This study prospectively evaluates the safety and efficacy of current and new design iterations of components of the FDA-cleared Spiracur SNaP Wound Care System in order to optimize safety, efficacy, and system performance.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Wound < 10 cm in greatest diameter
  • Patient >18 years of age
  • Willing and able to sign informed consent

排除标准

  • Patients with wound-related cellulitis
  • Patients with thick eschar at wound base post debridement
  • Patients with wounds located in an area not amenable to forming an air- tight seal
  • Ulcers due to inflammatory conditions such as pyodermagangrenosum, rheumatoid arthritis, vasculitis, cryoglobulinemia, necrobiosislipoidicadiabeticorum, lupus or pancreatic panniculitis, cryofibrinogenemia, calcinosis cutis, scleroderma, Raynaud's syndrome
  • Patient has untreated osteomyelitis
  • Patient is allergic to wound care products
  • Patient wounds with exposed blood vessels not suitable for negative pressure therapy
  • Pregnant or pregnancy-suspected patients
  • Subject actively participating in other clinical trials that conflict with the current study

结局指标

主要结局

Frequency of complaints about device use and operation

时间窗: 16 weeks

次要结局

未报告次要终点

研究者

发起方
3M
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验